Nobuyo Higashi‐Kuwata

Author

National Center for Global Health and Medicine ORCID

Also Known As

Nobuyo HIGASHI-KUWATA, Nobuyo Higashi-Kuwata, Nobuyo Higashi‐Kuwata

Publications

965

Citations

H-Index

Concepts

All Affiliations

National Center for Global Health and Medicine National Cancer Institute Kumamoto University National Institutes of Health Kumamoto University Hospital

About

Nobuyo Higashi‐Kuwata is an author at National Center for Global Health and Medicine specializing in natural sciences, engineering, and organic chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	1	1	10
2	Natural Sciences	1	1	10
3	Biochemistry	1	1	10
4	Biomolecular Engineering	1	1	10
5	Pharmacology	1	1	10

Nobuyo Higashi‐Kuwata

Publications

784

Citations

H-Index

Page 1

	Year	Citations
Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis Nobuyo Higashi‐Kuwata, Masatoshi Jinnin, Takamitsu Makino, Arthritis Research & Therapy	2010	232
A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication Shin-ichiro Hattori, Nobuyo Higashi‐Kuwata, Hironori Hayashi, Nature Communications	2021	190
Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma Kenji Maeda, Nobuyo Higashi‐Kuwata, Noriko Kinoshita, Scientific Reports	2021	54
4′‐modified nucleoside analogs: Potent inhibitors active against entecavir‐resistant hepatitis B virus Yuki Takamatsu, Yasuhito Tanaka, Satoru Kohgo, Hepatology	2015	52
A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency Manabu Aoki, Hironori Hayashi, Kalapala Venkateswara Rao, eLife	2017	51
Identification of SARS-CoV-2 Mpro inhibitors containing P1’ 4-fluorobenzothiazole moiety highly active against SARS-CoV-2 Nobuyo Higashi‐Kuwata, Kohei Tsuji, Hironori Hayashi, Nature Communications	2023	44
Identification of a novel long-acting 4’-modified nucleoside reverse transcriptase inhibitor against HBV Nobuyo Higashi‐Kuwata, Sanae Hayashi, Hiroki Kumamoto, Journal of Hepatology	2020	28
Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters Yuki Takamatsu, Masaki Imai, Kenji Maeda, Journal of Virology	2021	25
Structure–Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, Journal of Medicinal Chemistry	2023	23
Potent and biostable inhibitors of the main protease of SARS-CoV-2 Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, iScience	2022	21

Page 1